Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Inv. presentation
Director departure
|
|
NovaBay Pharmaceuticals, Inc. (NBY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 10% stake in NOVABAY PHARMACEUTICALS, INC. |
| 02/04/2022 |
SC 13G
| Hudson Bay Capital Management LP reports a 10% stake in NovaBay Pharmaceuticals, Inc. |
| 08/19/2019 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 6.9% stake in Novabay Pharmaceuticals, Inc. |
| 08/15/2019 |
SC 13G
| Empery Asset Management, LP reports a 8.4% stake in NovaBay Pharmaceuticals, Inc. |
| 02/12/2013 |
SC 13G
| Iroquois Capital Management, LLC reports a 7.6% stake in NOVABAY PHARMACEUTICALS, INC. |
| 09/24/2012 |
SC 13G
| Pioneer Pharma Pte. Ltd. reports a 5.2% stake in NOVABAY PHARMACEUTICALS, INC. |
| 07/05/2011 |
SC 13G
| NovaBay Pharmaceuticals, Inc. reports a 9.9% stake in NovaBay Pharmaceuticals, Inc. |
| 02/11/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/11/2008 |
SC 13G
| Najafi Ramin reports a 14.7% stake in NOVABAY PHARMACEUTICALS, INC. |
|
|